Skip to content

The effect of semi-occluded vocal tract treatment methods on improving voice quality in patients with unilateral vocal fold paralysis.

The effect of semi-occluded vocal tract treatment methods on improving voice quality in patients with unilateral vocal fold paralysis.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250227064867N1
Enrollment
15
Registered
2025-03-06
Start date
2025-04-03
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Unilateral vocal fold paralysis. G53.8* Cranial nerve disorders in diseases classified elsewhere. Other cranial nerve disorders in other diseases classified elsewhere.

Interventions

Intervention group: There is an intervention group consisting of 15 patients with unilateral vocal fold paralysis, all of whom receive 10 sessions of semi-occluded vocal tract therapy. These patients

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Diagnosis of unilateral vocal fold paralysis disorder by the main operator and otolaryngologist based on stroboscopy observations. Vocal fold paralysis within 3 months after thyroid surgery. No history of voice therapy, medication, or any surgical or medical treatment due to unilateral vocal fold paralysis, based on the medical record, The age range of patients with unilateral vocal fold paralysis is between 18 and 65 years, No history of head trauma, stroke, or head surgery based on medical records, Absence of paresis in the contralateral crease based on stroboscopy and interpretation by an otolaryngologist, No oscoliosis and severe lordosis in patients, No history of other functional and vocal organ disorders, No history of respiratory diseases including asthma and dyspnea, No history of psychopathy and use of neuroleptics and sedatives, No neurogenic diseases such as Parkinson's, Unwillingness to participate or continue treatment at any stage will lead to the patient's withdrawal from the study, Occurrence of stroke or any neurological disorder during treatment and study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Improving sound quality based on the results of acoustic, perceptual-auditory, aerodynamic, and self-assessment parameters based on the Persian version of the VAPP questionnaire. Timepoint: Before starting treatment, at the end of the last treatment session, and one month after completing treatment sessions. Method of measurement: Evaluation of acoustic parameters using data from PRAAT software using the patient's recorded voice. Evaluation of perceptual-auditory parameters based on the GRBAS assessment form score. Evaluation of acoustic parameters based on the maximum duration of vocalization obtained by a timer. Evaluation of self-assessment using the score obtained from the Persian version of the VAPP questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Salime Jafari

Shiraz University of Medical Sciences

SaJafari@Sums.ac.ir+98 71 3212 2600

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026